A systematic review of the safety of probiotics
Abstract
INTRODUCTION: There is growing evidence on the use of probiotics in various diseases, especially in gastrointestinal (GI) diseases. Although probiotics have been found helpful in many illnesses, they do not always seem to be safe. Through interference with commensal microflora, they can result in opportunistic performances in the host due to bacterimia and fungemia. Since considerable numbers of consumers use probiotic products worldwide, assurance of safety of these products is necessary. AREAS COVERED: This review evaluates all the existing information about the safety of probiotics in humans and animal models up to May 2013. In all eligible published studies in which adverse effects and tolerability of probiotics were investigated and reported, no language limitations were applied. The main key search terms were 'probiotics,' 'safety,' 'side effects,' 'clinical trial' and 'adverse effects.' The vast majority of trials investigated Bifidobacterium (B) and Lactobacillus (L) species. EXPERT OPINION: The main observed adverse effects of probiotics were sepsis, fungemia and GI ischemia. Generally, critically ill patients in intensive care units, critically sick infants, postoperative and hospitalized patients and patients with immune-compromised complexity were the most at-risk populations. While the overwhelming existing evidence suggests that probiotics are safe, complete consideration of risk-benefit ratio before prescribing is recommended.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
A systematic literature review of probiotic safety published in 2014 reported that the overwhelming existing evidence suggests that probiotics are safe for the general population, and that critically ill patients, postoperative and hospitalized patients and immunocompromised patients were the most at-risk groups wherein adverse events occurred.
“A systematic literature review of probiotic safety published in 2014 reported that “the overwhelming existing evidence suggests that probiotics are safe” for the general population, and that critically ill patients, postoperative and hospitalized patients and immunocompromised patients were the most at-risk groups wherein AEs occurred [220].”
From International Society of Sports Nutrition Position Stand: Probiotics (2019) · cites this paper as [220]
Cites
Diversity of the Human Intestinal Microbial Flora
Eckburg, P. B., Bik, E. M., Bernstein, C. N., Purdom, E., Dethlefsen, L., Sargent, M., Gill, S. R., Nelson, K. E., & Relman, D. A. (2005) · Science · doi:10.1126/science.1110591 · Cited by 7,913 · see citing works
Bifidobacteria can protect from enteropathogenic infection through production of acetate
Fukuda, S., Toh, H., Hase, K., Oshima, K., Nakanishi, Y., Yoshimura, K., Tobe, T., Clarke, J. M., Topping, D. L., Suzuki, T., et al. (2011) · Nature · doi:10.1038/nature09646 · Cited by 2,387 · see citing works
Gionchetti, P., Rizzello, F., Venturi, A., Brigidi, P., Matteuzzi, D., Bazzocchi, G., Poggioli, G., Miglioli, M., & Campieri, M. (2000) · Gastroenterology · doi:10.1053/gast.2000.9370 · Cited by 1,485 · see citing works
Probiotic bacteria: safety, functional and technological properties
Saarela, M., Mogensen, G., Fondén, R., Mättö, J., & Mattila-Sandholm, T. (2000) · Journal of Biotechnology · doi:10.1016/s0168-1656(00)00375-8 · Cited by 1,202 · see citing works
Probiotics, Prebiotics, and Synbiotics
de Vrese, M., & Schrezenmeir, J. (2008) · Advances in biochemical engineering, biotechnology · doi:10.1007/10_2008_097 · Cited by 1,033 · see citing works
Yogurt as probiotic carrier food
Lourens-Hattingh, A., & Viljoen, B. C. (2001) · International Dairy Journal · doi:10.1016/s0958-6946(01)00036-x · Cited by 932 · see citing works
Probiotics and the gut microbiota in intestinal health and disease
Gareau, M. G., Sherman, P. M., & Walker, W. A. (2010) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.117 · Cited by 907 · see citing works
McFarland, L. V. (1994) · JAMA · doi:10.1001/jama.1994.03510480037031 · Cited by 862 · see citing works
Whorwell, P. J., Altringer, L., Morel, J., Bond, Y., Charbonneau, D., O'Mahony, L., Kiely, B., Shanahan, F., & Quigley, E. M. M. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00734.x · Cited by 799 · see citing works
Enterococci as probiotics and their implications in food safety
Franz, C. M. A. P., Huch, M., Abriouel, H., Holzapfel, W. H., & Gálvez, A. (2011) · International Journal of Food Microbiology · doi:10.1016/j.ijfoodmicro.2011.08.014 · Cited by 795 · see citing works
Lin, H.-C., Su, B.-H., Chen, A.-C., Lin, T.-W., Tsai, C.-H., Yeh, T.-F., & Oh, W. (2005) · Pediatrics · doi:10.1542/peds.2004-1463 · Cited by 660 · see citing works
<i>Lactobacillus</i> Sepsis Associated With Probiotic Therapy
Land, M. H., Rouster-Stevens, K., Woods, C. R., Cannon, M. L., Cnota, J., & Shetty, A. K. (2005) · Pediatrics · doi:10.1542/peds.2004-2137 · Cited by 599 · see citing works
Oral Probiotics Prevent Necrotizing Enterocolitis in Very Low Birth Weight Neonates
Bin-Nun, A., Bromiker, R., Wilschanski, M., Kaplan, M., Rudensky, B., Caplan, M., & Hammerman, C. (2005) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2005.03.054 · Cited by 590 · see citing works
Updated Meta-analysis of Probiotics for Preventing Necrotizing Enterocolitis in Preterm Neonates
Deshpande, G. C., Rao, S. C., Patole, S., & Bulsara, M. K. (2010) · PEDIATRICS · doi:10.1542/peds.2009-1301 · Cited by 530 · see citing works
Lin, H.-C., Hsu, C.-H., Chen, H.-L., Chung, M.-Y., Hsu, J.-F., Lien, R.-I., Tsao, L.-Y., Chen, C.-H., & Su, B.-H. (2008) · Pediatrics · doi:10.1542/peds.2007-3007 · Cited by 506 · see citing works
Rayes, N., Seehofer, D., Hansen, S., Boucsein, K., Müller, A., Serke, S., Bengmark, S., & Neuhaus, P. (2002) · Transplantation · doi:10.1097/00007890-200207150-00021 · Cited by 488 · see citing works
Saccharomyces cerevisiae Fungemia: An Emerging Infectious Disease
Munoz, P., Bouza, E., Cuenca-Estrella, M., Eiros, J. M., Perez, M. J., Sanchez-Somolinos, M., Rincon, C., Hortal, J., & Pelaez, T. (2005) · Clinical Infectious Diseases · doi:10.1086/429916 · Cited by 462 · see citing works
Salminen, M. K., Rautelin, H., Tynkkynen, S., Poussa, T., Saxelin, M., Valtonen, V., & Jarvinen, A. (2004) · Clinical Infectious Diseases · doi:10.1086/380455 · Cited by 426 · see citing works
Salminen, M. K., Tynkkynen, S., Rautelin, H., Saxelin, M., Vaara, M., Ruutu, P., Sarna, S., Valtonen, V., & Järvinen, A. (2002) · Clinical Infectious Diseases · doi:10.1086/342912 · Cited by 419 · see citing works
Hoyos, A. B. (1999) · International Journal of Infectious Diseases · doi:10.1016/s1201-9712(99)90024-3 · Cited by 385 · see citing works
Sugawara, G., Nagino, M., Nishio, H., Ebata, T., Takagi, K., Asahara, T., Nomoto, K., & Nimura, Y. (2006) · Annals of Surgery · doi:10.1097/01.sla.0000219039.20924.88 · Cited by 348 · see citing works
Gastrointestinal microflora, food components and colon cancer prevention
Davis, C. D., & Milner, J. A. (2009) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2009.06.001 · Cited by 335 · see citing works
Canani, R. B., Cirillo, P., Terrin, G., Cesarano, L., Spagnuolo, M. I., Vincenzo, A. D., Albano, F., Passariello, A., Marco, G. D., Manguso, F., et al. (2007) · BMJ · doi:10.1136/bmj.39272.581736.55 · Cited by 328 · see citing works
Two cases of Lactobacillus bacteremia during probiotic treatment of short gut syndrome
Kunz, A. N., Noel, J. M., & Fairchok, M. P. (2004) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/00005176-200404000-00017 · Cited by 319 · see citing works
Early administration of Bifidobacterium breve to preterm infants: randomised controlled trial
Kitajima, H., Sumida, Y., Tanaka, R., Yuki, N., Takayama, H., & Fujimura, M. (1997) · Archives of Disease in Childhood Fetal & Neonatal · doi:10.1136/fn.76.2.f101 · Cited by 315 · see citing works
Probiotics and Prebiotics: Effects on Diarrhea1
de Vrese, M., & Marteau, P. R. (2007) · The Journal of Nutrition · doi:10.1093/jn/137.3.803s · Cited by 312 · see citing works
Laitinen, K., Poussa, T. A., Isolauri, E., & the Nutrition, A. (2008) · British Journal Of Nutrition · doi:10.1017/s0007114508111461 · Cited by 309 · see citing works
Manzoni, P., Mostert, M., Leonessa, M., Priolo, C., Farina, D., Monetti, C., Latino, M. A., & Gomirato, G. (2006) · Clinical Infectious Diseases · doi:10.1086/504324 · Cited by 305 · see citing works
De Groote, M. A., Frank, D. N., Dowell, E., Glode, M. P., & Pace, N. R. (2005) · Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000154588.79356.e6 · Cited by 284 · see citing works
Probiotics and health: An evidence-based review
Aureli, P., Capurso, L., Castellazzi, A. M., Clerici, M., Giovannini, M., Morelli, L., Poli, A., Pregliasco, F. E., Salvini, F. M., & Zuccotti, G. (2011) · Pharmacological Research · doi:10.1016/j.phrs.2011.02.006 · Cited by 281 · see citing works
Saccharomyces boulardii prevents diarrhea in critically ill tube-fed patients
Bleichner, G., Bléhaut, H., Mentec, H., & Moyse, D. (1997) · Intensive Care Medicine · doi:10.1007/s001340050367 · Cited by 254 · see citing works
Possible Role of Catheters in Saccharomyces boulardii Fungemia
Hennequin, C., Kauffmann‐Lacroix, C., Jobert, A., Viard, J., Ricour, C., Jacquemin, J. L., & Berche, P. (2000) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s100960050003 · Cited by 253 · see citing works
Rayes, N., Hansen, S., Seehofer, D., Müller, A. R., Serke, S., Bengmark, S., & Neuhaus, P. (2002) · Nutrition · doi:10.1016/s0899-9007(02)00811-0 · Cited by 253 · see citing works
Szajewska, H., Gyrczuk, E., & Horvath, A. (2012) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2012.08.004 · Cited by 244 · see citing works
Enteral feeding of premature infants with Lactobacillus GG.
Millar, M. R., Bacon, C., Smith, S. L., Walker, V., & Hall, M. A. (1993) · Archives of Disease in Childhood · doi:10.1136/adc.69.5_spec_no.483 · Cited by 242 · see citing works
Seven cases of fungemia with Saccharomyces boulardii in critically ill patients
Lherm, T., Monet, C., Nougière, B., Soulier, M., Larbi, D., Gall, C. L., Caen, D., & Malbrunot, C. (2002) · Intensive Care Medicine · doi:10.1007/s00134-002-1267-9 · Cited by 239 · see citing works
Marteau, P., & Shanahan, F. (2003) · Best practice & research. Clinical gastroenterology · doi:10.1016/s1521-6918(03)00055-6 · Cited by 238 · see citing works
Anti-inflammatory effects of probiotic yogurt in inflammatory bowel disease patients
Baroja, M. L., Kirjavainen, P. V., Hekmat, S., & Reid, G. (2007) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2007.03434.x · Cited by 234 · see citing works
Lactobacillus reuteri CRL1098 Produces Cobalamin
Taranto, M. P., Vera, J. L., Hugenholtz, J., de Valdez, G. F., & Sesma, F. J. M. (2003) · Journal of Bacteriology · doi:10.1128/jb.185.18.5643-5647.2003 · Cited by 221 · see citing works
Kukkonen, A. K., Savilahti, E., Haahtela, T., Juntunen‐Backman, K., Korpela, R., Poussa, T. A., Tuure, T., & Kuitunen, M. (2008) · PEDIATRICS · doi:10.1542/peds.2007-1192 · Cited by 220 · see citing works
Samanta, M., Sarkar, M., Ghosh, P., Ghosh, J., Sinha, M. K., & Chatterjee, S. (2008) · Journal of Tropical Pediatrics · doi:10.1093/tropej/fmn091 · Cited by 219 · see citing works
Rougé, C., Piloquet, H., Butel, M., Berger, B. W., Rochat, F., Ferraris, L., Robert, C. D., Legrand, A., de la Cochetière, M.-F., Nguyen, J., et al. (2009) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.26919 · Cited by 216 · see citing works
Cassone, M., Serra, P., Mondello, F., Girolamo, A., Scafetti, S., Pistella, E., & Venditti, M. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.11.5340-5343.2003 · Cited by 215 · see citing works
Henker, J., Laass, M. W., Blokhin, B. M., Bolbot, Y. K., Maydannik, V. G., Elze, M., Wolff, C., & Schulze, J. (2007) · European Journal of Pediatrics · doi:10.1007/s00431-007-0419-x · Cited by 199 · see citing works
Lactobacilli and Bacteremia in Southern Finland, 1989-1992
Saxelin, M., Chuang, N.-H., Chassy, B., Rautelin, H., Makela, P. H., Salminen, S., & Gorbach, S. L. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/22.3.564 · Cited by 186 · see citing works
Enteral feeding of premature infants with Saccharomyces boulardii
Costalos, C., Skouteri, V., Gounaris, A., Sevastiadou, S., Triandafilidou, A., Ekonomidou, C., Kontaxaki, F., & Petrochilou, V. (2003) · Early Human Development · doi:10.1016/s0378-3782(03)00090-2 · Cited by 185 · see citing works
Lavermicocca, P., Valerio, F., Lonigro, S. L., Angelis, M. D., Morelli, L., Callegari, M. L., Rizzello, C. G., & Visconti, A. (2005) · Applied and Environmental Microbiology · doi:10.1128/aem.71.8.4233-4240.2005 · Cited by 184 · see citing works
Forestier, C., Guélon, D., Cluytens, V., Gillart, T., Sirot, J., & de Champs, C. (2008) · Critical Care · doi:10.1186/cc6907 · Cited by 178 · see citing works
Rinkinen, M. L., Jalava, K., Westermarck, E., Salminen, S., & Ouwehand, A. C. (2002) · Veterinary Microbiology · doi:10.1016/s0378-1135(02)00356-5 · Cited by 177 · see citing works
Rahimi, R., Nikfar, S., Rahimi, F. C., Elahi, B., Derakhshani, S., Vafaie, M., & Abdollahi, M. R. (2008) · Digestive Diseases and Sciences · doi:10.1007/s10620-007-0171-0 · Cited by 173 · see citing works
Self-citationOhishi, A., Takahashi, S., Ito, Y., Ohishi, Y., Tsukamoto, K., Nanba, Y., Ito, N., Kakiuchi, S., Saitoh, A., Morotomi, M., et al. (2010) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2009.11.041 · Cited by 171 · see citing works
Underwood, M. A., Salzman, N. H., Bennett, S. H., Barman, M., Mills, D. A., Marcobal, A. M., Tancredi, D. J., Bevins, C. L., & Sherman, M. P. (2009) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e31818de195 · Cited by 169 · see citing works
Alberda, C., Gramlich, L. M., Meddings, J. B., Field, C. J., McCargar, L., Kutsogiannis, D. J., Fedorak, R. N., & Madsen, K. L. (2007) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/85.3.816 · Cited by 166 · see citing works
Probiotic microbes: do they need to be alive to be beneficial?
Kataria, J., Li, N., Wynn, J. L., & Neu, J. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.2009.00226.x · Cited by 158 · see citing works
Production of Menaquinones by Lactic Acid Bacteria
Morishita, T., Tamura, N., Makino, T., & Kudo, S. (1999) · Journal of Dairy Science · doi:10.3168/jds.s0022-0302(99)75424-x · Cited by 157 · see citing works
Efficacy of Probiotics in Irritable Bowel Syndrome: A Meta-Analysis of Randomized, Controlled Trials
Nikfar, S., Rahimi, R., Rahimi, F., Derakhshani, S., & Abdollahi, M. (2008) · Diseases of the Colon & Rectum · doi:10.1007/s10350-008-9335-z · Cited by 155 · see citing works
Self-citationFunctional foods and the immune system: a review
López-Varela, S., González‐Gross, M., & Marcos, A. (2002) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1601481 · Cited by 153 · see citing works
Zhou, J. S., Shu, Q., Rutherfurd, K. J., Prasad, J., Birtles, M. J., Gopal, P. K., & Gill, H. S. (2000) · International Journal of Food Microbiology · doi:10.1016/s0168-1605(00)00219-1 · Cited by 142 · see citing works
Evaluation of Bifidobacterium breve strain Yakult-fermented soymilk as a probiotic food
Shimakawa, Y. (2002) · International Journal of Food Microbiology · doi:10.1016/s0168-1605(02)00224-6 · Cited by 141 · see citing works
Effects of bifidobacterium breve supplementation on intestinal flora of low birth weight infants
Li, Y., Shimizu, T., Hosaka, A., Kaneko, N., Ohtsuka, Y., & Yamashiro, Y. (2004) · Pediatrics International · doi:10.1111/j.1442-200x.2004.01953.x · Cited by 140 · see citing works
Intestinal colonization, microbiota, and probiotics
Salminen, S., & Isolauri, E. (2006) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2006.06.062 · Cited by 134 · see citing works
Zhou, J. S., Shu, Q., Rutherfurd, K. J., Prasad, J., Gopal, P. K., & Gill, H. S. (2000) · Food and Chemical Toxicology · doi:10.1016/s0278-6915(99)00154-4 · Cited by 131 · see citing works
Elahi, B., Nikfar, S., Derakhshani, S., Vafaie, M., & Abdollahi, M. R. (2007) · Digestive Diseases and Sciences · doi:10.1007/s10620-007-0006-z · Cited by 131 · see citing works
Self-citationHoneycutt, T., Khashab, M. E., Wardrop, R. M., McNeal-Trice, K. A., Honeycutt, A. L. B., Christy, C. G., Mistry, K. P., Harris, B. D., Meliones, J. N., & Kocis, K. C. (2007) · Pediatric Critical Care Medicine · doi:10.1097/01.pcc.0000282176.41134.e6 · Cited by 130 · see citing works
Pro- and Synbiotics to Control Inflammation and Infection in Patients With Multiple Injuries
Giamarellos‐Bourboulis, E. J., Bengmark, S., Kanellakopoulou, K., & Kotzampassi, K. E. (2009) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0b013e31819d979e · Cited by 129 · see citing works
Knight, D. J., Gardiner, D. D., Banks, A., Snape, S. E., Weston, V. C., Bengmark, S., & Girling, K. J. (2008) · Intensive Care Medicine · doi:10.1007/s00134-008-1368-1 · Cited by 125 · see citing works
Probiotics and gut health: A special focus on liver diseases
Gratz, S. W. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i4.403 · Cited by 124 · see citing works
Probiotics for the treatment of eczema: a systematic review
Boyle, R. J., Bath-Hextall, F. J., Leonardi‐Bee, J., Murrell, D. F., & Tang, M. L. K. (2009) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2009.03305.x · Cited by 122 · see citing works
Schneider, S. M. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i39.6165 · Cited by 120 · see citing works
Fukushima, Y., Miyaguchi, S., Yamano, T., Kaburagi, T., Iino, H., Ushida, K., & Sato, K. (2007) · British Journal Of Nutrition · doi:10.1017/s0007114507764723 · Cited by 114 · see citing works
Qin, H.-L., Zheng, J.-J., Tong, D.-N., Chen, W.-X., Fan, X.-B., Hang, X., & Jiang, Y.-Q. (2007) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602792 · Cited by 106 · see citing works
Perapoch, J., Planes, A. M., Querol, A., L�pez, V. N., Mart�nez-Benday�n, I., Tormo, R., Fern�ndez, F., Peguero, G., & Salcedo, S. (2000) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s100960000295 · Cited by 102 · see citing works
Fungemia with Saccharomyces boulardii in a 1-Year-Old Girl with Protracted Diarrhea
Pletincx, M., Legein, J., & Vandenplas, Y. (1995) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/00005176-199507000-00022 · Cited by 102 · see citing works
Probiotics in Clinical Practice: An Overview
Zuccotti, G., Meneghin, F., Raimondi, C., Dilillo, D., Agostoni, C. V., Riva, E., & Giovannini, M. (2008) · Journal of International Medical Research · doi:10.1177/14732300080360s101 · Cited by 99 · see citing works
Possible Confounding Factors in an Oral Probiotics Trial: Breast Milk: In Reply
Lin, H., Su, B., & Tsai, C. (2005) · PEDIATRICS · doi:10.1542/peds.2005-0245 · Cited by 95 · see citing works
Wang, C., Shoji, H., Sato, H., Nagata, S., Ohtsuka, Y., Shimizu, T., & Yamashiro, Y. (2007) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/01.mpg.0000252184.89922.5f · Cited by 94 · see citing works
Waitzberg, D. L., Logullo, L., Bittencourt, A. F., Torrinhas, R. S., Shiroma, G. M., Paulino, N. P., & Teixeira-da-Silva, M. L. (2012) · Clinical Nutrition · doi:10.1016/j.clnu.2012.08.010 · Cited by 92 · see citing works
Klarin, B., Wullt, M., Palmquist, I., Molin, G., LARSSON, A., & Jeppsson, B. W. (2008) · Acta Anaesthesiologica Scandinavica · doi:10.1111/j.1399-6576.2008.01748.x · Cited by 90 · see citing works
Shimizu, K., Ogura, H., Goto, M., Asahara, T., Nomoto, K., Morotomi, M., Matsushima, A., Tasaki, O., Fujita, K., Hosotsubo, H., et al. (2008) · Digestive Diseases and Sciences · doi:10.1007/s10620-008-0460-2 · Cited by 85 · see citing works
VSL#3 Probiotic Upregulates Intestinal Mucosal Alkaline Sphingomyelinase and Reduces Inflammation
Soo, I., Madsen, K. L., Tejpar, Q., Sydora, B. C., Sherbaniuk, R. W., Cinque, B., Marzio, L. D., Cifone, M. G., Desimone, C., & Fedorak, R. N. (2008) · Canadian Journal of Gastroenterology · doi:10.1155/2008/520383 · Cited by 80 · see citing works
Probiotics in the Development and Treatment of Allergic Disease
Isolauri, E., Rautava, S., & Salminen, S. (2012) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2012.08.007 · Cited by 78 · see citing works
Salari (2012) · doi:10.2174/187152812798889394 · Cited by 78 · see citing works
Self-citationKlarin, B., Johansson, M.-L., Molin, G., Larsson, A. O., & Jeppsson, B. W. (2005) · Critical Care · doi:10.1186/cc3522 · Cited by 77 · see citing works
Clinical Safety of Lactobacillus casei shirota as a Probiotic in Critically Ill Children
Srinivasan, R., Meyer, R. W., Ramnarayan, P., & Britto, J. F. (2006) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/01.mpg.0000189335.62397.cf · Cited by 73 · see citing works
Fungemia Due toSaccharomycesSpecies in a Patient Treated with EnteralSaccharomyces boulardii
Niault, M. A., Thomas, F., Prost, J., Ansari, F. H., & Kalfon, P. (1999) · Clinical Infectious Diseases · doi:10.1086/517255 · Cited by 72 · see citing works
Saccharomyces boulardii fungaemia in an intensive care unit patient treated with caspofungin
Lolis, N. V., Veldekis, D., Moraitou, H., Kanavaki, S., Velegraki, A., Charis, T., Chronis, T., Pefanis, A. V., & Pneumatikos, I. A. (2008) · Critical Care · doi:10.1186/cc6843 · Cited by 70 · see citing works
Rijnders, B. J. A., Wijngaerden, E. V., Verwaest, C., & Peetermans, W. E. (2000) · Intensive Care Medicine · doi:10.1007/s001340051261 · Cited by 63 · see citing works
Marcobal, A. M., Underwood, M. A., & Mills, D. A. (2008) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e3181660694 · Cited by 56 · see citing works
Potential uses of probiotics in the neonate
Rautava, S. (2006) · Seminars in Fetal and Neonatal Medicine · doi:10.1016/j.siny.2006.10.006 · Cited by 52 · see citing works
Saccharomyces boulardiiFungemia in a Patient Receiving Ultra‐levure Therapy
Frédénucci, I., Chomarat, M., Boucaud, C., & Flandrois, J. (1998) · Clinical Infectious Diseases · doi:10.1086/517685 · Cited by 51 · see citing works
Jones, M. L., Martoni, C., Tamber, S., Parent, M., & Prakash, S. (2012) · Food and Chemical Toxicology · doi:10.1016/j.fct.2012.03.010 · Cited by 49 · see citing works
SACCHAROMYCES CEREVISIAE FUNGEMIA IN AN ELDERLY PATIENT WITH CLOSTRIDIUM DIFFICILE COLITIS
Cherifi, S., Robberecht, J., & Miendje, Y. (2004) · Acta Clinica Belgica · doi:10.1179/acb.2004.033 · Cited by 49 · see citing works
Narayanappa, D. (2008) · The Indian Journal of Pediatrics · doi:10.1007/s12098-008-0134-2 · Cited by 47 · see citing works
Fungämie nach oraler Gabe vonSaccharomyces boulardiibei einem multimorbiden Patienten
Lestin-Bernstein, F., Pertschy, A., & Rimek, D. (2003) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/s-2003-44948 · Cited by 47 · see citing works
Fongémie à Saccharomyces boulardii chez un brûlé grave
Viggiano, M., Badetti, C., Bernini, V., Garabedian, M., & Manelli, J. C. (1995) · Annales Françaises d Anesthésie et de Réanimation · doi:10.1016/s0750-7658(05)80603-3 · Cited by 45 · see citing works
Helping patients make informed choices about probiotics: a need for research
Sharp, R. R., Achkar, J.-P., Brinich, M. A., & Farrell, R. M. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2008.68 · Cited by 43 · see citing works
Routine Probiotic Use in Very Preterm Infants: Retrospective Comparison of Two Cohorts
Bonsante, F., Iacobelli, S., & Gouyon, J. (2012) · American Journal of Perinatology · doi:10.1055/s-0032-1321498 · Cited by 42 · see citing works
[Saccharomyces boulardii fungemia. Apropos of a case].
Zunic, P., Lacotte, J., Pegoix, M., Buteux, G., Leroy, G., Mosquet, B., & Moulin, M. (1991) · PubMed · Cited by 41 · see citing works
B‐Vitamin Content of Natural Lactic Acid Fermented Cornmeal
Murdock, F. A., & FIELDS, M. L. (1984) · Journal of Food Science · doi:10.1111/j.1365-2621.1984.tb12425.x · Cited by 38 · see citing works
Besselink, M. G., van Santvoort, H. C., Buskens, E., Boermeester, M. A., van Goor, H., Timmerman, H. M., Nieuwenhuijs, V. B., Bollen, T. L., van Ramshorst, B., Witteman, B. J. M., et al. (2008) · PubMed · Cited by 38 · see citing works
Burkhardt, O., Köhnlein, T., Pletz, M. W., & Welte, T. (2005) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540510026454 · Cited by 37 · see citing works
Probiotics, Prebiotics, Energy Balance, and Obesity
Molinaro, F., Paschetta, E., Cassader, M., Gambino, R., & Musso, G. (2012) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2012.08.009 · Cited by 37 · see citing works
Henry, S., D'Hondt, L. A., André, M. P. E., Holemans, X., & Canon, J. L. (2004) · Acta Clinica Belgica · doi:10.1179/acb.2004.032 · Cited by 36 · see citing works
Saadatzadeh, A., Atyabi, F., Fazeli, M. R., Dinarvand, R., Jamalifar, H., Abdolghaffari, A. H., Mahdaviani, P., Mahbod, M., Baeeri, M., Baghaei, A., et al. (2011) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2011.00966.x · Cited by 35 · see citing works
Self-citationProbiotics use to treat irritable bowel syndrome
Hosseini, A., Nikfar, S., & Abdollahi, M. R. (2012) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2012.707179 · Cited by 35 · see citing works
Self-citationEffects of Probiotics on Acquisition and Spread of Multiresistant Enterococci
de Regt, M. J. A., Willems, R. J. L., Hené, R. J., Siersema, P. D., Verhaar, H. J. J., Hopmans, T. E. M., & Bonten, M. J. M. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01765-09 · Cited by 32 · see citing works
Candy, D. C. A., Densham, L., Lamont, L. S., Greig, M., Lewis, J., Bennett, H., & Griffiths, M. (2001) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/00005176-200104000-00027 · Cited by 29 · see citing works
Probiotics and Necrotizing Enterocolitis: Finding the Missing Pieces of the Probiotic Puzzle
Luedtke, S. A., Yang, J. T., & Wild, H. E. (2012) · The Journal of Pediatric Pharmacology and Therapeutics · doi:10.5863/1551-6776-17.4.308 · Cited by 25 · see citing works
Product Development of Probiotics as Biological Drugs
Sutton, A. (2008) · Clinical Infectious Diseases · doi:10.1086/523325 · Cited by 22 · see citing works
Transgenic probiotica as drug delivery systems: the golden bullet?
Yuvaraj, S., Peppelenbosch, M. P., & Bos, N. A. (2006) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.4.1.1 · Cited by 21 · see citing works
Methaemoglobinaemia with concurrent blood isolation of Saccharomyces and Candida
Lungarotti, M. S., Mezzetti, D., & Radicioni, M. (2003) · Archives of Disease in Childhood Fetal & Neonatal · doi:10.1136/fn.88.5.f446 · Cited by 20 · see citing works
Editorial Are probiotics effective in management of irritable bowel syndrome?
Hosseini, A., Nikfar, S., & Abdollahi, M. R. (2012) · Archives of Medical Science · doi:10.5114/aoms.2012.29396 · Cited by 17 · see citing works
Self-citationPotential hazards of probiotic bacteria for immunodeficient patients
Wagner, R. D., & Balish, E. (1998) · Bulletin de l Institut Pasteur · doi:10.1016/s0020-2452(98)80011-0 · Cited by 17 · see citing works
Potential benefits of probiotics – main findings of an in-depth review
Weichselbaum, E. (2010) · British Journal of Community Nursing · doi:10.12968/bjcn.2010.15.3.46897 · Cited by 15 · see citing works
On the benefit of whey-cultured Lactobacillus casei in murine colitis.
Ghasemi‐Niri, S. F., Abdolghaffari, A. H., Fallah-Benakohal, S., Hosseinpour-Feizi, M., Mahdaviani, P., Jamalifar, H., Baeeri, M., Dehghan, G., & Abdollahi, M. R. (2011) · PubMed · Cited by 12 · see citing works
Self-citationGhasemi‐Niri, S. F., Solki, S., Didari, T., Mozaffari, S., Baeeri, M., Rezvanfar, M. A., Mohammadir, A., Jamalifar, H., & Abdollahi, M. R. (2012) · Asian Journal of Animal and Veterinary Advances · doi:10.3923/ajava.2012.1148.1156 · Cited by 7 · see citing works
Self-citationSaccharomyces boulardii prevents diarrhea in critically ill tube fed patients
Bleichner, G., & Bléhaut, H. (1994) · Clinical Nutrition · doi:10.1016/0261-5614(94)90145-7 · Cited by 1 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
The pros, cons, and many unknowns of probiotics
Suez, J., Zmora, N., Segal, E., & Elinav, E. (2019) · Nature Medicine · doi:10.1038/s41591-019-0439-x · Cited by 1,398 · see citing works
Mechanisms of action of probiotics
Plaza-Diaz, J., Ruiz-Ojeda, F. J., Gil-Campos, M., & Gil, A. (2019) · Advances in Nutrition · doi:10.1093/advances/nmy063 · Cited by 1,423 · see citing works
“The effects of probiotics on host health have been reported in many articles, reviews, and systematic reviews (12, 13).”
BackgroundMicroorganisms with Claimed Probiotic Properties: An Overview of Recent Literature
Fijan, S. (2014) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph110504745 · Cited by 1,059 · see citing works
“The most common types of microorganisms used as probiotics are lactic acid bacteria and bifidobacteria, although other bacteria and certain yeasts are also used [17].”
BackgroundProbiotics for the prevention of pediatric antibiotic-associated diarrhea
Goldenberg, J. Z., Lytvyn, L., Steurich, J., Parkin, P. C., Mahant, S., & Johnston, B. C. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004827.pub4 · Cited by 625 · see citing works
The gut microbiota influences anticancer immunosurveillance and general health
Routy, B., Gopalakrishnan, V., Daillère, R., Zitvogel, L., Wargo, J. A., & Kroemer, G. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0006-2 · Cited by 523 · see citing works
Prebiotics and Probiotics in Digestive Health
Quigley, E. M. M. (2018) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.09.028 · Cited by 387 · see citing works
The Unregulated Probiotic Market
de Simone, C. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.01.018 · Cited by 317 · see citing works
Didari, T. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i10.3072 · Cited by 356 · see citing works
Self-citationInternational Society of Sports Nutrition Position Stand: Probiotics
Jäger, R., Mohr, A. E., Carpenter, K. C., Kerksick, C. M., Purpura, M., Moussa, A., Townsend, J. R., Lamprecht, M., West, N. P., Black, K., et al. (2019) · Journal of the International Society of Sports Nutrition · doi:10.1186/s12970-019-0329-0 · Cited by 277 · see citing works
Probiotics for the prevention of pediatric antibiotic-associated diarrhea
Guo, Q., Goldenberg, J. Z., Humphrey, C., El Dib, R., & Johnston, B. C. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004827.pub5 · Cited by 275 · see citing works
Vallianou, N. G., Stratigou, T., Christodoulatos, G. S., Tsigalou, C., & Dalamaga, Μ. (2020) · Current Obesity Reports · doi:10.1007/s13679-020-00379-w · Cited by 251 · see citing works
Alcon-Giner, C., Dalby, M. J., Caim, S., Ketskemety, J., Shaw, A., Sim, K., Lawson, M. A., Kiu, R., Leclaire, C., Chalklen, L., et al. (2020) · Cell Reports Medicine · doi:10.1016/j.xcrm.2020.100077 · Cited by 229 · see citing works
“Concerns have been raised about the safety of using probiotic bacteria in vulnerable individuals.(55) However, no adverse effects were observed to result from over 5 years of routine clinical use of probiotics used in this study.”
BackgroundHasain, Z., Mokhtar, N. M., Kamaruddin, N. A., Ismail, N. A. M., Razalli, N. H., Gnanou, J. V., & Ali, R. A. R. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00188 · Cited by 234 · see citing works
“Consumption of probiotics requires constant monitoring, as some adverse effects, such as systemic infections, mild gastrointestinal upset, and skin complications, have been reported in ill infants, elderly, immunocompromised individuals, and hospitalized patients (Didari et al., 2014; Sotoudegan et al., 2019).”
BackgroundGutiérrez‐Castrellón, P., Gandara-Martí, T., y Abreu, A. T. A., Nieto-Rufino, C. D., López-Orduña, E., Jiménez–Escobar, I., Jiménez-Gutiérrez, C., López‐Velázquez, G., & Espadaler, J. (2022) · Gut Microbes · doi:10.1080/19490976.2021.2018899 · Cited by 216 · see citing works
Antidepressive Mechanisms of Probiotics and Their Therapeutic Potential
Yong, S. J., Tong, T., Chew, J., & Lim, W. L. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01361 · Cited by 217 · see citing works
Diet Supplementation, Probiotics, and Nutraceuticals in SARS-CoV-2 Infection: A Scoping Review
Infusino, F., Marazzato, M., Mancone, M., Fedele, F., Mastroianni, C. M., Severino, P., Ceccarelli, G., Santinelli, L., Cavarretta, E., Marullo, A. G. M., et al. (2020) · Nutrients · doi:10.3390/nu12061718 · Cited by 202 · see citing works
“Similarly, in patients with severe disease and in critically ill patients, probiotic administration needs to be cautiously evaluated, and important safety concerns need to be considered when administering bacterial supplements [89].”
BackgroundLipid-modifying effects of nutraceuticals: An evidence-based approach
Sahebkar, A., Șerban, M.-C., Gluba-Brzózka, A., Mikhailidis, D. P., Cicero, A. F. G., Rysz, J., & Banach, M. (2016) · Nutrition · doi:10.1016/j.nut.2016.04.007 · Cited by 188 · see citing works
Hsieh, M., Tsai, W.-H., Jheng, Y.-P., Su, S., Wang, S., Lin, C., Chen, Y.-H., & Chang, W. (2018) · Scientific Reports · doi:10.1038/s41598-018-35014-1 · Cited by 182 · see citing works
The involvement of gut microbiota in inflammatory bowel disease pathogenesis: Potential for therapy
Cammarota, G., Ianiro, G., Cianci, R., Bibbò, S., Gasbarrini, A., & Currò, D. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.12.006 · Cited by 180 · see citing works
“available systematic reviews of the literature agree on the partial, but not total, safety of probiotics (Didari et al., 2014; Whelan & Myers, 2010).”
BackgroundKijmanawat, A., Panburana, P., Reutrakul, S., & Tangshewinsirikul, C. (2018) · Journal of Diabetes Investigation · doi:10.1111/jdi.12863 · Cited by 176 · see citing works
A critical review of antibiotic resistance in probiotic bacteria
Li, T., Teng, D., Mao, R., Hao, Y., Wang, X., & Wang, J. (2020) · Food Research International · doi:10.1016/j.foodres.2020.109571 · Cited by 172 · see citing works
Wan, M. L. Y., Forsythe, S. J., & El-Nezami, H. S. (2018) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2018.1490885 · Cited by 180 · see citing works
“…and Bifidobacterium species are commonly used as probiotics in fermented dairy products (Kirpich and McClain 2012), although other bacteria including Enterococcus spp., Leuconostoc spp. and certain yeasts such as Saccharomyces spp. have also been used as probiotics (Didari et al. 2014).”
MethodProbiotics, fibre and herbal medicinal products for functional and inflammatory bowel disorders
Currò, D., Ianiro, G., Pecere, S., Bibbò, S., & Cammarota, G. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13632 · Cited by 160 · see citing works
“Some systematic reviews of the literature have tried to address it and they agreed that probiotics can be considered partially, but not totally, safe (Whelan and Myers, 2010; Didari et al., 2014).”
BackgroundBrain fogginess, gas and bloating: a link between SIBO, probiotics and metabolic acidosis
Rao, S. S. C., Rehman, A., Yu, S. W. B., & de Andino, N. M. (2018) · Clinical and Translational Gastroenterology · doi:10.1038/s41424-018-0030-7 · Cited by 163 · see citing works
Bafeta, A., Koh, M., Riveros, C., & Ravaud, P. (2018) · Annals of Internal Medicine · doi:10.7326/m18-0343 · Cited by 162 · see citing works
“Median patients randomly assigned per study (interquartile range), n 62 (43-120)”
Pregnancy outcomes in women taking probiotics or prebiotics: a systematic review and meta-analysis
Jarde, A., Lewis-Mikhael, A.-M., Moayyedi, P., Stearns, J. C., Collins, S. M., Beyene, J., & McDonald, S. D. (2018) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-017-1629-5 · Cited by 161 · see citing works
“They can be given as biological supplements or in food [3] such as yogurt, [4] making them readily available for consumption.”
BackgroundEncapsulation: A Strategy to Deliver Therapeutics and Bioactive Compounds?
Klojdová, I., Milota, T., Smetanová, J., & Stathopoulos, C. E. (2023) · Pharmaceuticals · doi:10.3390/ph16030362 · Cited by 155 · see citing works
“The use of probiotics has been associated with a higher risk of infection and/or morbidity in young infants and postoperative, hospitalized or immuno-compromised patients, in part due to bacteraemia and fungaemia [54].”
BackgroundCano‐Garrido, O., Seras‐Franzoso, J., & García‐Fruitós, E. (2015) · Microbial Cell Factories · doi:10.1186/s12934-015-0313-6 · Cited by 148 · see citing works
“Besides, it should be noted that some adverse effects of LAB have been reported [104] [105] [106] .”
BackgroundWang, S., Xiao, Y., Tian, F., Zhao, J., Zhang, H., Zhai, Q., & Chen, W. (2020) · Journal of Functional Foods · doi:10.1016/j.jff.2020.103838 · Cited by 146 · see citing works
Changing our microbiome: probiotics in dermatology
Yu, Y., Dunaway, S., Champer, J., Kim, J., & Alikhan, A. (2019) · British Journal of Dermatology · doi:10.1111/bjd.18088 · Cited by 144 · see citing works
Clinical implications of preterm infant gut microbiome development
Healy, D., Ryan, C. A., Ross, R. P., Stanton, C., & Dempsey, E. M. (2021) · Nature Microbiology · doi:10.1038/s41564-021-01025-4 · Cited by 132 · see citing works
Probiotics for treating eczema
Makrgeorgou, A., Leonardi‐Bee, J., Bath-Hextall, F. J., Murrell, D. F., Tang, M. L. K., Roberts, A., & Boyle, R. J. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006135.pub3 · Cited by 130 · see citing works
Reis, D. J., Ilardi, S. S., & Punt, S. E. W. (2018) · PLOS ONE · doi:10.1371/journal.pone.0199041 · Cited by 123 · see citing works
Crosstalk between the microbiome and cancer cells by quorum sensing peptides
Wynendaele, E., Verbeke, F., D’Hondt, M., Hendrix, A., de Wiele, C. V., Burvenich, C., Peremans, K. Y., Wever, O. D., Bracke, M., & Spiegeleer, B. M. J. D. (2015) · Peptides · doi:10.1016/j.peptides.2014.12.009 · Cited by 115 · see citing works
“bacteremia, fungemia and gastrointestinal ischemia; critically ill patients and immune-compromised individuals are the most-at-risk populations [9].”
Strategies to Improve Meat Products’ Quality
Ursachi, C. Ș., Perța-Crișan, S., & Munteanu, F. (2020) · Foods · doi:10.3390/foods9121883 · Cited by 125 · see citing works
“The main species of microorganisms used as probiotics in food products are Lactobacillus and Bifidobacterium but have also been reported a lot of other species of bacteria (Lactococcus, Enterococcus, Propionibacterium) or yeasts (Saccharomyces) that are also available [73].”
BackgroundNutrition in the Intensive Care Unit—A Narrative Review
Hill, A., Elke, G., & Weimann, A. (2021) · Nutrients · doi:10.3390/nu13082851 · Cited by 114 · see citing works
“Their administration is a challenging concept with a potential impact on diarrhea and infectious complications [62,63].”
BackgroundExploring biotechnological and functional characteristics of probiotic yeasts: A review
Shruthi, B., Deepa, N., Somashekaraiah, R., Adithi, G., Divyashree, S., & Sreenivasa, M. Y. (2022) · Biotechnology Reports · doi:10.1016/j.btre.2022.e00716 · Cited by 114 · see citing works
“The yeast species Debaryomyces hansenii, which have the capacity to tolerate high salt concentration, isolated from several natural environments and foods, found to obtain advantageous and useful effect for applications as probiotics in Pisces [2] .”
BackgroundPrebiotics and Probiotics for Gastrointestinal Disorders
Rau, S., Gregg, A., Yaceczko, S. D., & Limketkai, B. N. (2024) · Nutrients · doi:10.3390/nu16060778 · Cited by 121 · see citing works
“A 2014 systematic review described several cases of bacteremia with Lactobacillus strains ( L. rhamnosus GG, in particular) and fungemia in ICU patients with a central venous catheter receiving S. boulardii [179].”
BackgroundBifidobacterium Bacteremia: Clinical Characteristics and a Genomic Approach To Assess Pathogenicity
Esaiassen, E., Hjerde, E., Cavanagh, J. P., Simonsen, G. S., & Klingenberg, C. (2017) · Journal of Clinical Microbiology · doi:10.1128/jcm.00150-17 · Cited by 108 · see citing works
“Although probiotic products generally are regarded as safe, vigilance regarding their potential virulence, antibacterial resistance, and adverse metabolic activity should be maintained, in particular, in patients with predisposing or underlying conditions, such as gastrointestinal surgery, malignancy, or immunodeficie…”
BackgroundTette, F.-M., Kwofie, S. K., & Wilson, M. D. (2022) · Current Issues in Molecular Biology · doi:10.3390/cimb44040096 · Cited by 114 · see citing works
Lehtoranta, L., Latvala, S., & Lehtinen, M. J. (2020) · Nutrients · doi:10.3390/nu12103163 · Cited by 103 · see citing works
Using probiotics for type 2 diabetes mellitus intervention: Advances, questions, and potential
Sun, Z., Sun, X., Li, J., Li, Z., Hu, Q., Li, L., Hao, X., Song, M., & Li, C. (2020) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2018.1547268 · Cited by 117 · see citing works
“Although probiotic are generally regarded as safe (GRAS), careful consideration of side effects before application is still recommended, as adverse effects of probiotics, like sepsis, fungemia, and gastrointestinal ischemia are occasionally reported, especially in critically ill patients (Didari et al. 2014).”
BackgroundShobeiri, P., Kalantari, A., Teixeira, A. L., & Rezaei, N. (2022) · Biology of Sex Differences · doi:10.1186/s13293-022-00422-6 · Cited by 105 · see citing works
“Probiotics including Lactobacillus and Bifidobacterium species have been evaluated as therapeutic agents in various mental and neurodegenerative disorders [332].”
BackgroundPourjafar, H., Ansari, F., Sadeghi, A., Samakkhah, S. A., & Jafari, S. M. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2047883 · Cited by 103 · see citing works
“Accordingly, complete consideration of risk-benefit ratio as well as in vitro, in vivo, and in situ evaluation of safety aspects before acceptance of potentially probiotic microorganisms as GRAS or qualified presumption of their safety status is recommended (Didari et al. 2014).”
BackgroundAgamennone, V., Krul, C. A. M., Rijkers, G. T., & Kort, R. (2018) · BMC Gastroenterology · doi:10.1186/s12876-018-0831-x · Cited by 97 · see citing works
“patients, immuno-compromised patients are at high risk [23, 24]).”
BackgroundAntibiotic resistance propagation through probiotics
Daniali, M., Nikfar, S., & Abdollahi, M. (2020) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2020.1825682 · Cited by 90 · see citing works
Self-citationRecent insights into the nutritional immunomodulation of cancer‐related microRNAs
Şahin, T. Ö., Yılmaz, B., Yeşilyurt, N., Cicia, D., Szymanowska, A., Amero, P., Ağagündüz, D., & Capasso, R. (2023) · Phytotherapy Research · doi:10.1002/ptr.7937 · Cited by 87 · see citing works
“In addition, it was stated that probiotics might have side effects, as well as beneficial effects on health and safety issues, which might arise due to the use of microbial cells (Didari et al., 2014).”
BackgroundŽučko, J., Starčević, A., Diminić, J., Oros, D., Mortazavian, A. M., & Putnik, P. (2020) · Current Opinion in Food Science · doi:10.1016/j.cofs.2020.01.007 · Cited by 89 · see citing works
Potential Probiotic Yeasts Sourced from Natural Environmental and Spontaneous Processed Foods
Agarbati, A., Canonico, L., Marini, E., Zannini, E., Ciani, M., & Comitini, F. (2020) · Foods · doi:10.3390/foods9030287 · Cited by 85 · see citing works
“Currently, it represents the most common human probiotic yeast studied in detail and available on the market [13].”
BackgroundTan‐Lim, C. S. C., Esteban‐Ipac, N. A. R., Mantaring, J. B. V., Shih‐Yen, E. C., Recto, M. S. T., Sison, O. T., & Alejandria, M. M. (2020) · Pediatric Allergy and Immunology · doi:10.1111/pai.13305 · Cited by 84 · see citing works
Effect of Bifidobacterium on osteoclasts: TNF-α/NF-κB inflammatory signal pathway-mediated mechanism
Wu, Y., Yang, Y., Wang, L., Chen, Y., Han, X., Sun, L., Chen, H., & Chen, Q. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1109296 · Cited by 83 · see citing works
“Several research and clinical studies have demonstrated that, probiotics, despite their disease-prevention and treatment effects, are not absolutely safe or without side effects (33).”
BackgroundProbiotics: Should All Patients Take Them?
Katkowska, M., Garbacz, K., & Kusiak, A. (2021) · Microorganisms · doi:10.3390/microorganisms9122620 · Cited by 82 · see citing works
“Furthermore, it has been shown that, although very rarely, probiotic strains cause infections in humans [26,28,29].”
BackgroundGut microbiota and sepsis: from pathogenesis to novel treatments
Kullberg, R. F. J., Wiersinga, W. J., & Haak, B. W. (2021) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000781 · Cited by 78 · see citing works
“difficile infection have been earlier described, especially in critically ill patients and infants [39,40].”
BackgroundHarms Reporting in Randomized Controlled Trials of Interventions Aimed at Modifying Microbiota
Bafeta, A., Koh, M., Riveros, C., & Ravaud, P. (2019) · Annals of Internal Medicine · doi:10.7326/l18-0562 · Cited by 76 · see citing works
Choi, G. H., Holzapfel, W. H., & Todorov, S. D. (2022) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2022.2090227 · Cited by 78 · see citing works
“In addition to the LAB, other Gram-positive bacteria such as the bifidobacteria belonging to the phylum Actinobacteria, along with certain Gram-negative bacteria belonging to the Proteobacteria have been applied as probiotics (Didari et al. 2014).”
BackgroundWastyk, H. C., Perelman, D., Topf, M. A., Fragiadakis, G. K., Robinson, J. L., Sonnenburg, J. L., Gardner, C. D., & Sonnenburg, E. D. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2178794 · Cited by 68 · see citing works
“In general, probiotic supplements are considered extremely safe, however, there have been reports that probiotics can lead to acute issues such as sepsis and gastrointestinal issues in individuals with compromised immune systems.(22) Similarly, probiotic supplementation can hinder microbiome recovery after antibiotic…”
BackgroundMolecular genetics for probiotic engineering: dissecting lactic acid bacteria
Suissa, R., Oved, R., Jankelowitz, G., Turjeman, S. C., Koren, O., & Kolodkin‐Gal, I. (2021) · Trends in Microbiology · doi:10.1016/j.tim.2021.07.007 · Cited by 68 · see citing works
Pagnini, C., Corleto, V. D., Martorelli, M., Lanini, C., D’Ambra, G., Giulio, E. D., & Fave, G. D. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i41.4652 · Cited by 67 · see citing works
Approach to the diagnosis and management of dysbiosis
Alagiakrishnan, K., Morgadinho, J., & Halverson, T. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1330903 · Cited by 75 · see citing works
“In immunocompromised or critically ill people, probiotics can increase opportunistic infections and so a risk benefit assessment should be done before recommending these products (235).”
BackgroundIacumin, L., Ginaldi, F., Manzano, M., Anastasi, V., Reale, A., Zotta, T., Rossi, F., Coppola, R., & Comi, G. (2014) · Food Microbiology · doi:10.1016/j.fm.2014.08.007 · Cited by 66 · see citing works
Seven cases of Saccharomyces fungaemia related to use of probiotics
Roy, U., Jessani, L. G., Rudramurthy, S. M., Gopalakrishnan, R., Dutta, S., Chakravarty, C., Jillwin, J., & Chakrabarti, A. (2017) · Mycoses · doi:10.1111/myc.12604 · Cited by 66 · see citing works
Tan‐Lim, C. S. C., Esteban‐Ipac, N. A. R., Recto, M. S. T., Castor, M. A. R., Casis‐Hao, R. J., & Nano, A. L. M. (2021) · Pediatric Allergy and Immunology · doi:10.1111/pai.13514 · Cited by 65 · see citing works
Miller, L. E., Lehtoranta, L., & Lehtinen, M. J. (2017) · Nutrients · doi:10.3390/nu9030191 · Cited by 64 · see citing works
“lactis HN019 has an impact on immune cell function in blood; however, it remains unknown if the stimulatory effect would have been maintained in longer term consumption [45].”
BackgroundIn vitro investigation of Debaryomyces hansenii strains for potential probiotic properties
Ochangco, H. S., Gamero, A., Smith, I. M., Christensen, J. E., Jespersen, L., & Arneborg, N. (2016) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-016-2109-1 · Cited by 59 · see citing works
Contemporary meta-analysis of short-term Probiotic consumption on gastrointestinal transit
Miller, L. E., Zimmermann, A. K., & Ouwehand, A. C. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i21.5122 · Cited by 57 · see citing works
Probiotics for oral and vulvovaginal candidiasis: A review
Shenoy, A., & Gottlieb, A. B. (2019) · Dermatologic Therapy · doi:10.1111/dth.12970 · Cited by 78 · see citing works
Probiotics and their Beneficial Health Effects
Zaib, S., Hayat, A., & Khan, I. A. (2023) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557523666230608163823 · Cited by 59 · see citing works
Obuchowska, A., Gorczyca, K., Standyło, A., Obuchowska, K., Kimber-Trojnar, Ż., Wierzchowska-Opoka, M., & Leszczyńska‐Gorzelak, B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158253 · Cited by 56 · see citing works
“Nevertheless, side effects such as systemic infections, mild gastrointestinal disturbances and skin complications have been reported [5,10].”
BackgroundA cell-free, biomimetic hydrogel based on probiotic membrane vesicles ameliorates wound healing
Kuhn, T., Aljohmani, A., Frank, N. A., Zielke, L., Mehanny, M., Laschke, M. W., Koch, M., Hoppstädter, J., Kiemer, A. K., Yildiz, D., et al. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.12.011 · Cited by 56 · see citing works
Immunosuppression and probiotics: are they effective and safe?
Stadlbauer, V. (2015) · Beneficial Microbes · doi:10.3920/bm2015.0065 · Cited by 56 · see citing works
Invasive Infections Associated with the Use of Probiotics in Children: A Systematic Review
D’Agostin, M., Squillaci, D., Lazzerini, M., Barbi, E., Wijers, L., & Lozzo, P. D. (2021) · Children · doi:10.3390/children8100924 · Cited by 56 · see citing works
“However, only a few systematic safety studies have been carried out, particularly in vulnerable populations, and most of the existing published studies on probiotics have not specifically reported safety, leaving uncertainties regarding their potential risks [15,16].”
BackgroundBekiaridou, Α., Karlafti, E., Oikonomou, I. M., Ioannidis, A., & Papavramidis, T. S. (2021) · Nutrients · doi:10.3390/nu13124265 · Cited by 55 · see citing works
“Theoretical risks that include systemic infections and excessive immune response have been described without observational data [45,46].”
BackgroundProbiotics and postbiotics play a role in maintaining dermal health
Rawal, S., & Ali, S. A. (2023) · Food & Function · doi:10.1039/d3fo00152k · Cited by 56 · see citing works
Alam, Z., Shang, X., Effat, K., Kanwal, F., He, X., Li, Y., Xu, C., Niu, W., War, A. R., & Zhang, Y. (2022) · Journal of Food Biochemistry · doi:10.1111/jfbc.14302 · Cited by 53 · see citing works
Awuchi, C. G., & Okpala, C. O. R. (2022) · Journal of Food Bioactives · doi:10.31665/jfb.2022.18317 · Cited by 52 · see citing works
Value of Probiotics in Canine and Feline Gastroenterology
Schmitz, S. S. (2020) · Veterinary Clinics of North America Small Animal Practice · doi:10.1016/j.cvsm.2020.09.011 · Cited by 52 · see citing works
Zhang, L., Xu, J.-Y., Xing, Y., Wu, P., Jin, Y.-W., Wei, W., Zhao, L., Yang, J., Chen, G., & Qin, L. (2024) · Microbiological Research · doi:10.1016/j.micres.2024.127821 · Cited by 50 · see citing works
Chen, Y., Qi, A., Teng, D., Li, S., Yan, Y., Hu, S., & Du, X. (2022) · Techniques in Coloproctology · doi:10.1007/s10151-022-02585-1 · Cited by 49 · see citing works
“Therefore, probiotics and synbiotics should be used in consideration of their possible side effects, which need to be confirmed by more studies [38].”
BackgroundNutraceuticals as modulators of gut microbiota: Role in therapy
Quigley, E. M. M. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14902 · Cited by 47 · see citing works
Probiotics in obstetrics and gynaecology
Griffin, C. J. (2015) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/ajo.12303 · Cited by 47 · see citing works
Saccharomyces cerevisiae fungemia after probiotic treatment in an intensive care unit patient
Kara, İ., Yıldırım, F., ., O. O., Erganiş, S., Aydoğdu, M., Dizbay, M., Gürsel, G., & Kalkancı, A. (2017) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2017.09.003 · Cited by 46 · see citing works
Garg, V., Velumani, D., Lin, Y.-C., & Haye, A. (2024) · PharmaNutrition · doi:10.1016/j.phanu.2024.100423 · Cited by 44 · see citing works
A Brief Overview on Probiotics: The Health Friendly Microbes
Mishra, S., & Acharya, S. (2021) · Biomedical & Pharmacology Journal · doi:10.13005/bpj/2285 · Cited by 46 · see citing works
Probiotics and their applications in functional foods: a health perspective
Amin, M. R., Biswas, A. P., Tasnim, M., Islam, M. N., & Azam, M. S. (2025) · Applied Food Research · doi:10.1016/j.afres.2025.101193 · Cited by 46 · see citing works
Gut Microbiome and Common Variable Immunodeficiency: Few Certainties and Many Outstanding Questions
Varricchi, G., Poto, R., Ianiro, G., Punziano, A., Marone, G., Gasbarrini, A., & Spadaro, G. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.712915 · Cited by 44 · see citing works
“Finally, synbiotics themselves can be associated with adverse events and their safety profile is often overlooked (205, 206).”
BackgroundDealing with the remaining controversies of probiotic safety
van den Nieuwboer, M., & Claassen, E. (2019) · Beneficial Microbes · doi:10.3920/bm2018.0159 · Cited by 41 · see citing works
Probiotic-Associated Aspiration Pneumonia Due to Lactobacillus rhamnosus
Doern, C. D., Nguyen, S. T., Afolabi, F., & Burnham, C.-A. D. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.01065-14 · Cited by 41 · see citing works
“Lactobacilli are low-virulence organisms that are commensals of the genitourinary and gastrointestinal tracts and are commonly used as probiotic supplements (15).”
BackgroundAntibiotics and probiotics in inflammatory bowel disease: when to use them?
Abraham, B. P., & Quigley, E. M. M. (2019) · Frontline Gastroenterology · doi:10.1136/flgastro-2018-101057 · Cited by 39 · see citing works
“62 63 Since probiotic strains typically do not colonise the adult colon and repeated or indefinite use is required for an ongoing effect, long-term maintenance studies in IBD are needed.”
The potential role of interventions impacting on gut-microbiota in epilepsy
Iannone, L. F., Gómez-Eguílaz, M., Citaro, R., & Russo, E. (2020) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2020.1759414 · Cited by 38 · see citing works
Probiotics and human lactational mastitis: A scoping review
Barker, M., Adelson, P., Peters, M. D. J., & Steen, M. (2020) · Women and Birth · doi:10.1016/j.wombi.2020.01.001 · Cited by 36 · see citing works
Gut Microbiota Modulation: Implications for Infection Control and Antimicrobial Stewardship
Tan, G. S. E., Tay, H. L., Tan, S. H., Lee, T. H., Ng, T. M., & Lye, D. C. (2020) · Advances in Therapy · doi:10.1007/s12325-020-01458-z · Cited by 37 · see citing works
Altered gut microbiome associated with overactive bladder and daily urinary urgency
Okamoto, T., Hatakeyama, S., Imai, A., Yamamoto, H., Yoneyama, T., Mori, K., Yoneyama, T., Hashimoto, Y., Nakaji, S., & Οhyama, C. (2020) · World Journal of Urology · doi:10.1007/s00345-020-03243-7 · Cited by 34 · see citing works
“Some bacteria of the genus Bifidobacterium may play critical beneficial roles and have been used as probiotics [28, 29].”
BackgroundProbiotics in health and disease: fooling Mother Nature?
Abid, M. B., & Koh, C. J. (2019) · Infection · doi:10.1007/s15010-019-01351-0 · Cited by 35 · see citing works
Catho, G., & Huttner, B. D. (2019) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2019.1645007 · Cited by 33 · see citing works
“So far there is no evidence for the impact of probiotics on decolonization and caution should be taken before applying probiotics for this purpose in routine clinical practice, since manipulation of the microbiome could lead to unintended consequences and probiotics may also be the cause of infections, particularly in…”
BackgroundStrategies for the Development of Bioprotective Cultures in Food Preservation
Souza, L. V., Martins, E., Moreira, I. M. F. B., & de Carvalho, A. F. (2022) · International Journal of Microbiology · doi:10.1155/2022/6264170 · Cited by 32 · see citing works
Rousseau, A., & Martindale, R. G. (2024) · Annals of Intensive Care · doi:10.1186/s13613-024-01350-x · Cited by 32 · see citing works
“Due to their immunocompromised status, critically ill patients are at risk of bacteremia or fungemia secondary to probiotics administration [113].”
BackgroundChen, Y., Yue, R., Zhang, B., Li, Z., Shui, J., & Huang, X. (2019) · Medicina Clínica · doi:10.1016/j.medcli.2019.05.041 · Cited by 32 · see citing works
Das, S., Vishakha, K., Banerjee, S., Bera, T., Mondal, S., & Ganguli, A. (2022) · Current Research in Microbial Sciences · doi:10.1016/j.crmicr.2022.100150 · Cited by 32 · see citing works
Abdollahi, M. R., Abdolghaffari, A. H., Gooshe, M., & Ghasemi‐Niri, S. F. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-802189-7.00015-0 · Cited by 32 · see citing works
Self-citationDinić, M., Burgess, J. L., Lukić, J., Catanuto, P., Radojević, D., Marjanović, J., Verpile, R., Thaller, S. R., Gonzalez, T., Golić, N., et al. (2024) · The FASEB Journal · doi:10.1096/fj.202400054rr · Cited by 31 · see citing works
“9,10 Commercially available probiotics can have a different ratio of living and dead bacterial cells, depending on the methods of formulation, which can affect biological effect after application.”
- Authors
- Didari, T., Solki, S., Mozaffari, S., Nikfar, S., & Abdollahi, M.
- Affiliations
- Islamic Azad University, Tehran (IR)
- Pharmaceutical Sciences Research Center (IR)
- Ministry of Health and Medical Education (IR)
- Venue
- Expert Opinion on Drug Safety
- Publisher
- Informa Healthcare
- Published
- 2014-01-03
- Volume
- 13
- Issue
- 2
- Pages
- 227-239
- ISSN
- 1474-0338 (ISSN-L)
- 1744-764X
- OpenAlex
- W2125631968
- Cited by
- 367
- References
- 117
- Citations by year
- 2026: 27 · 2025: 44 · 2024: 32 · 2023: 42 · 2022: 41 · 2021: 41 · 2020: 38 · 2019: 28 · 2018: 27 · 2017: 14 · 2016: 11 · 2015: 14 · 2014: 8
- FWCI
- 1.94
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Expert Opinion on Drug Safety (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Complementary and alternative medicine › Complementary and Alternative Medicine Studies
- Keywords
- probiotics, probiotic safety, adverse effects, sepsis, fungemia, gastrointestinal ischemia, Bifidobacterium, Lactobacillus, opportunistic infections, commensal microbiota, critically ill patients, immunocompromised patients, risk-benefit ratio
- MeSH terms
- Animals, Bifidobacterium, Humans, Lactobacillus, Safety, Probiotics, Drug-Related Side Effects and Adverse Reactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review